What is ADCT's dilution risk score?

ADCT has a latest available DilutionScore record of 56/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for ADCT, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for ADCT?

DilutionWatch tracks 25 SEC filing types for ADCT including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect ADCT shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For ADCT, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for ADCT tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for ADCT. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

ADCT Dilution Risk Score: 56/100 (HIGH)

Score Breakdown

📋 Offering Ability

66

💰 Cash Runway

25

📊 Float Risk

27

⚠️ Warrant Exposure

70

🔄 Convertible Debt

15

Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

model est. 31%

📜 Warrant Exercise model 40%

• Significant warrants: 22% of shares outstanding

• Elevated warrant risk score (70/100)

💰 Capital Raise model 38%

• Active shelf registration ($38M, 9% of market cap)

• Active ATM program with $38M remaining capacity

🔔 Track ADCT — Get forecast alerts →

Market Data

Market Cap$432.45M

Shares Outstanding127.67M

Float100.41M

Cash$219.11M

Debt$6.18M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 10.6% shares (2026Q1 vs prior)

118 institutional holders · 94.20M shares

#1 Redmile Group, LLC 15.47M shares

#2 TCG Crossover Management, LLC 11.39M shares

#3 MORGAN STANLEY 11.25M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.09M

Days to Cover6.1

% of Float5.1%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

xbrl XBRL CONVERTIBLE 2022-12-31

424B3 ATM 2026-04-15

4 INSIDER TRANSACTION 2026-04-02

424B3 ATM 2026-03-16

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual ADCT Dilution Snapshot

ADC Therapeutics SA (ADCT) has a DilutionScore of 56/100, rated High dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $37.5M.
Stored ATM program remaining capacity: $37.5M.
Stored outstanding warrants: 27.7M.
Recent SEC activity tracked for ADCT: xbrl on 2026-06-30; 424B3 on 2026-04-15; 4 on 2026-04-02.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.